AAAAAA

   
Results: 1-9 |
Results: 9
PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS
Authors: BAILEY H RIPPLE G GOULD M ARZOOMANIAN R ALBERTI D FEIERABEND C SIMON K MORGAN K TUTSCH K POMPLUN M WAHAMAKI A MARNOCHA R WILDING G
Citation: H. Bailey et al., PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS, Annals of oncology, 9, 1998, pp. 409-409
LACK OF THERMAL ENHANCEMENT FOR TAXANES IN-VITRO
Authors: RIETBROEK RC KATSCHINSKI DM REIJERS MHE ROBINS HI GEERDINK A TUTSCH K DOLEIRE F HAVEMAN J
Citation: Rc. Rietbroek et al., LACK OF THERMAL ENHANCEMENT FOR TAXANES IN-VITRO, International journal of hyperthermia, 13(5), 1997, pp. 525-533
CHEMOPREVENTION OF SPONTANEOUS INTESTINAL ADENOMAS IN THE APC MUTANT MIN MOUSE MODEL BY THE NONSTEROIDAL ANTIINFLAMMATORY DRUG PIROXICAM
Authors: JACOBY RF MARSHALL DJ NEWTON M TUTSCH K COLE CE LUBET RA KELLOFF GJ VERMA A MOSER AR DOVE WF
Citation: Rf. Jacoby et al., CHEMOPREVENTION OF SPONTANEOUS INTESTINAL ADENOMAS IN THE APC MUTANT MIN MOUSE MODEL BY THE NONSTEROIDAL ANTIINFLAMMATORY DRUG PIROXICAM, Gastroenterology, 110(4), 1996, pp. 535-535
CHEMOPREVENTION OF SPONTANEOUS INTESTINAL ADENOMAS IN THE APC (MIN) MOUSE MODEL BY THE NONSTEROIDAL ANTIINFLAMMATORY DRUG PIROXICAM
Authors: JACOBY RF MARSHALL DJ NEWTON MA NOVAKOVIC K TUTSCH K COLE CE LUBET RA KELLOFF GJ VERMA A MOSER AR DOVE WF
Citation: Rf. Jacoby et al., CHEMOPREVENTION OF SPONTANEOUS INTESTINAL ADENOMAS IN THE APC (MIN) MOUSE MODEL BY THE NONSTEROIDAL ANTIINFLAMMATORY DRUG PIROXICAM, Cancer research, 56(4), 1996, pp. 710-714
PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER
Authors: SCHILLER JH STORER B TUTSCH K ARZOOMANIAN R ALBERTI D FEIERABEND C SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 12(2), 1994, pp. 241-248
A PHASE-II STUDY OF VINBLASTINE IN COMBINATION WITH ACRIVASTINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: BERLIN J KING AC TUTSCH K FINDLAY JW KOHLER P COLLIER M CLENDENINN NJ WILDING G
Citation: J. Berlin et al., A PHASE-II STUDY OF VINBLASTINE IN COMBINATION WITH ACRIVASTINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Investigational new drugs, 12(2), 1994, pp. 137-141
A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SCHILLER JH STORER B TUTSCH K ARZOOMANIAN R ALBERTI D FEIERABEND C SPRIGGS D
Citation: Jh. Schiller et al., A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 21(5), 1994, pp. 9-14
CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND METABOLITES WITH AND WITHOUT SR-2508
Authors: CHAN KK HONG PS TUTSCH K TRUMP DL
Citation: Kk. Chan et al., CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND METABOLITES WITH AND WITHOUT SR-2508, Cancer research, 54(24), 1994, pp. 6421-6429
PHASE-I TRIAL OF MITOXANTRONE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES
Authors: SCHILLER JH STORER B ARZOOMANIAN R TUTSCH K ALBERTI D SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF MITOXANTRONE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Investigational new drugs, 11(4), 1993, pp. 291-300
Risultati: 1-9 |